Home/Filings/4/0001209191-21-031108
4//SEC Filing

Robbins Andrew R 4

Accession 0001209191-21-031108

CIK 0001708493other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 9:57 PM ET

Size

5.5 KB

Accession

0001209191-21-031108

Insider Transaction Report

Form 4
Period: 2021-05-04
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2021-05-04+10,16710,167 total
    Exercise: $22.50Exp: 2031-05-03Common Stock (10,167 underlying)
Footnotes (1)
  • [F1]The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001590157

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 9:57 PM ET
Size
5.5 KB